Virginia Retirement Systems’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,313
Closed -$228K 1321
2026
Q1
$228K Sell
14,313
-11,300
-44% -$245K ﹤0.01% 894
2025
Q4
$673K Sell
25,613
-2,500
-9% -$64.9K ﹤0.01% 694
2025
Q3
$635K Sell
28,113
-5,200
-16% -$107K ﹤0.01% 710
2025
Q2
$662K Buy
33,313
+2,400
+8% +$46.8K ﹤0.01% 693
2025
Q1
$522K Buy
+30,913
New +$527K ﹤0.01% 737
2023
Q3
$543K Sell
20,300
-700
-3% -$23.9K 0.01% 671
2023
Q2
$778K Sell
21,000
-800
-4% -$27.9K 0.01% 620
2023
Q1
$681K Hold
21,800
0.01% 656
2022
Q4
$649K Buy
21,800
+3,500
+19% +$125K 0.01% 753
2022
Q3
$698K Buy
+18,300
New +$917K 0.01% 696
2022
Q1
$992K Buy
15,900
+3,900
+33% +$257K 0.01% 645
2021
Q4
$1.21M Sell
12,000
-700
-6% -$61.5K 0.01% 598
2021
Q3
$1.14M Buy
12,700
+1,300
+11% +$118K 0.01% 573
2021
Q2
$1.05M Buy
11,400
+2,000
+21% +$160K 0.01% 634
2021
Q1
$908K Buy
9,400
+2,300
+32% +$237K 0.01% 692
2020
Q4
$370K Buy
+7,100
New +$297K ﹤0.01% 934

Other funds holding FLGT

Virginia Retirement Systems's FLGT Position: Q2 2026 in Review

Virginia Retirement Systems sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 14,313 shares — an estimated $228K sold.

Virginia Retirement Systems first reported a position in FLGT in Q4 2020 and held it in 16 quarters. The position peaked at $1.21M in Q4 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Virginia Retirement Systems reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 14,313 Fulgent Genetics shares in Q2 2026, an estimated $228K.
  • Virginia Retirement Systems first reported a position in Fulgent Genetics in Q4 2020 and held it in 16 quarters.
  • Virginia Retirement Systems's Fulgent Genetics position peaked at $1.21M in Q4 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.